Literature DB >> 19352681

Renal cell carcinoma associated immunosuppressive therapy: a case report with Wegener's granulomatosis.

Serpil Muge Deger1, Ruya Mutluay, Fatma Ayerden Ebinc, Turgay Arinsoy, Sukru Sindel.   

Abstract

Development of uroepithelial tumors after cyclophosphamide and azathioprine therapy in Wegener's granulomatosis (WG) have been reported in the literature but renal cell carcinoma (RCC), rarely. RCC associated with WG has been previously reported in a few cases. Most of them have simultaneous diseases. Here, we report a case, which developed RCC 8 years after initiation of WG. Long-term immunosuppressive treatment is a risk factor for the development of malignancies; it should be suggested that RCC in our patient might be due to immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352681     DOI: 10.1007/s00296-009-0911-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  Wegener's granulomatosis presenting with a renal mass.

Authors:  A Villa-Forte; G S Hoffman
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

2.  Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.

Authors:  John H Stone; Janet T Holbrook; Matthew A Marriott; Andrea K Tibbs; Lourdes P Sejismundo; Y-I Min; Ulrich Specks; Peter A Merkel; Robert Spiera; John C Davis; E William St Clair; W Joseph McCune; Steven R Ytterberg; Nancy B Allen; Gary S Hoffman
Journal:  Arthritis Rheum       Date:  2006-05

3.  Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.

Authors:  K W Westman; P G Bygren; H Olsson; J Ranstam; J Wieslander
Journal:  J Am Soc Nephrol       Date:  1998-05       Impact factor: 10.121

Review 4.  Malignancies associated with immunosuppressive or cytotoxic therapy.

Authors:  I Penn
Journal:  Surgery       Date:  1978-05       Impact factor: 3.982

5.  Hemorrhagic cystitis due to cyclophosphamide.

Authors:  R D Reynolds; J J Simerville; D D O'Hara; J B Hart; J E Parkinson
Journal:  J Urol       Date:  1969-01       Impact factor: 7.450

6.  Wegener's granulomatosis associated with renal cell carcinoma.

Authors:  E Tatsis; E Reinhold-Keller; K Steindorf; A C Feller; W L Gross
Journal:  Arthritis Rheum       Date:  1999-04

7.  Renal cell carcinoma associated with cyclophosphamide therapy for Wegener's granulomatosis.

Authors:  M Odeh
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

8.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

9.  An association between ANCA positive renal disease and malignancy.

Authors:  J D Edgar; D P Rooney; P McNamee; T A McNeill
Journal:  Clin Nephrol       Date:  1993-07       Impact factor: 0.975

10.  Ulcerative colitis complicated by renal cell carcinoma: a series of three patients.

Authors:  J Satsangi; J Marshall; D Roskell; D Jewell
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

View more
  3 in total

1.  Renal cancer and Wegener's granulomatosis: a case report.

Authors:  Uros Bumbasirevic; Dejan Dragicevic; Aleksandar Janicic; Vesna Cemerikic-Martinovic; Milica Cekerevac; Vuk Aleksic; Cane Tulic
Journal:  World J Surg Oncol       Date:  2011-12-13       Impact factor: 2.754

2.  Renal cell carcinoma with proliferative lupus nephritis.

Authors:  Koh-Wei Wong
Journal:  BMJ Case Rep       Date:  2015-01-16

3.  Primitive Neuroectodermal Tumor and Wegener's Granulomatosis of the Kidney: A Curious Combination of Two Rare Entities.

Authors:  Rugvedita Parakh; Satyajeet Parakh; Maria Tretiakova
Journal:  Case Rep Urol       Date:  2017-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.